Gene Therapy in Ophthalmology


Gene therapy in ophthalmology is propelling transformative advancements, offering hope for treating inherited eye diseases. This personalized precision approach, facilitated by emerging viral vector technologies, holds promise in restoring vision for those affected by conditions like Leber congenital amaurosis (LCA), retinitis pigmentosa, and choroideremia. Clinical successes underscore its potential, as patients have shown remarkable improvements, perceiving light, shapes, and even reading letters on an eye chart post-treatment.



Collaborative efforts among geneticists, ophthalmologists, and researchers fuel the field's progress. While challenges persist, such as refining vector delivery and ensuring affordability, gene therapy's trajectory promises a future where untreatable eye conditions can be managed or even cured through gene-based interventions. 


    Related Conference of Gene Therapy in Ophthalmology

    February 17-18, 2025

    11th Global Ophthalmology Meeting

    Amsterdam, Netherlands
    February 24-25, 2025

    9th World Congress on Eye and Vision

    Madrid, Spain
    March 17-18, 2025

    39th European Ophthalmology Congress

    Berlin, Germany
    April 07-08, 2025

    6th World congress on Ophthalmology and Optometry

    Amsterdam, Netherlands
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain
    April 29-30, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    June 12-13, 2025

    6th International Conference on Optometry

    London, UK

    Gene Therapy in Ophthalmology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in